Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit and Disruptive Behavior Disorders

Explore clinical trials studying Attention Deficit and Disruptive Behavior Disorders. Study availability and eligibility vary by location and protocol.

1,450 public trials 167 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit and Disruptive Behavior Disorders trial results

Completed

Preschool Supplement to Clonidine in ADHD (Kiddie-CAT)

NCT00414921

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • University of Rochester Medical Center, Department of Neurology, 919 Westfall Road, Building C Rochester, New York, United States
  • University of Cincinnati, Department of Psychiatry, 231 Albert Sabin Way, M: 0559 Cincinnati, Ohio, United States
  • Western Psychiatric Institute and Clinic, ADD Program, 3811 Ohara Street Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Clonidine in Attention Deficit Hyperactivity Disorder (ADHD) in Children

NCT00031395

Conditions
Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • SUNY Buffalo, Center For Children & Families Buffalo, New York, United States
  • University of Rochester, Department of Neurology Rochester, New York, United States
  • Children's Hospital Medical Center Cincinnati, Ohio, United States
  • Western Psychiatric Institute and Clinic Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia

NCT00318448

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +7 more
Locations
  • Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
  • Sanofi-Aventis Administrative Office Laval, Canada
View Trial Details
Completed

Comparison of Atomoxetine and Placebo in Children and Adolescents With ADHD and ODD

NCT00191698

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +3 more
Locations
  • For additional information regarding investigative sites for this trial, call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Wallsend, New South Wales, Australia
  • For additional information regarding investigative sites for this trial, call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Parkville, Victoria, Australia
  • For additional information regarding investigative sites for this trial, call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Antwerp, Belgium
  • For additional information regarding investigative sites for this trial, call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Brussels, Belgium
View all 16 locations
View Trial Details

Related conditions